Mirzyme Therapeutics Limited
10133310
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 19/04/2016
MEDICAL SCIENTIST & PRO-VICE-CHANCELLOR
BRITISH · UNITED KINGDOM · Age 66
Also on 1 other board
director · Since 03/10/2018
CHARTERED ACCOUNTANT
BRITISH · ENGLAND · Age 64
Also on 7 other boards
director · Since 11/09/2023
MEDICAL DOCTOR
BRITISH · ENGLAND · Age 62
Also on 7 other boards
Persons with Significant Control
Professor Asif Syed Ahmed
British · United Kingdom · Age 66
74, Lordswood Road, Birmingham, B17 9BY
Notified 19/04/2016
CompanyRankvs 691+ SIC 72110 peers68
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£100
Balance sheet strength
Cash
£314k
Cash in the bank
Net Current Assets
£224k
Working capital
Current Assets
£372k
Current Liabilities
£147k
Fixed Assets
£472k
Debtors
£57k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 2.52 |
| 2023 | 3.40 |
| 2022 | 9.92 |
| 2021 | 15.89 |
| 2020 | 18.96 |
| 2019 | 99.63 |
| 2018 | 85.00 |
| 2018 | 0.91 |
Derived from filed accounts. Not audited figures.